nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivermectin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.108	0.215	CbGbCtD
Ivermectin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0731	0.145	CbGbCtD
Ivermectin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0698	0.139	CbGbCtD
Ivermectin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0622	0.124	CbGbCtD
Ivermectin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0609	0.121	CbGbCtD
Ivermectin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0575	0.114	CbGbCtD
Ivermectin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0365	0.0726	CbGbCtD
Ivermectin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0345	0.0685	CbGbCtD
Ivermectin—GLRA3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.0102	0.0759	CbGpPWpGaD
Ivermectin—GLRA3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.0091	0.0676	CbGpPWpGaD
Ivermectin—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00463	0.0344	CbGpPWpGaD
Ivermectin—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00409	0.0304	CbGpPWpGaD
Ivermectin—GLRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00356	0.0264	CbGpPWpGaD
Ivermectin—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00335	0.0249	CbGpPWpGaD
Ivermectin—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00335	0.0249	CbGpPWpGaD
Ivermectin—GLRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00317	0.0235	CbGpPWpGaD
Ivermectin—NR1H4—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.00303	0.0225	CbGpPWpGaD
Ivermectin—GABRB3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00218	0.0162	CbGpPWpGaD
Ivermectin—NR1H4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00213	0.0158	CbGpPWpGaD
Ivermectin—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00564	CcSEcCtD
Ivermectin—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00204	0.00563	CcSEcCtD
Ivermectin—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00553	CcSEcCtD
Ivermectin—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.002	0.00551	CcSEcCtD
Ivermectin—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00199	0.0055	CcSEcCtD
Ivermectin—ABCG2—HIF-2-alpha transcription factor network—MMP14—chronic obstructive pulmonary disease	0.00199	0.0148	CbGpPWpGaD
Ivermectin—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00199	0.00547	CcSEcCtD
Ivermectin—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00198	0.00545	CcSEcCtD
Ivermectin—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00196	0.00541	CcSEcCtD
Ivermectin—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.00536	CcSEcCtD
Ivermectin—GABRB3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00194	0.0144	CbGpPWpGaD
Ivermectin—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00533	CcSEcCtD
Ivermectin—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00189	0.00521	CcSEcCtD
Ivermectin—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00188	0.00519	CcSEcCtD
Ivermectin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00188	0.00517	CcSEcCtD
Ivermectin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00182	0.00502	CcSEcCtD
Ivermectin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00181	0.005	CcSEcCtD
Ivermectin—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00489	CcSEcCtD
Ivermectin—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00489	CcSEcCtD
Ivermectin—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00177	0.00489	CcSEcCtD
Ivermectin—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00176	0.00484	CcSEcCtD
Ivermectin—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00174	0.0048	CcSEcCtD
Ivermectin—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00174	0.0048	CcSEcCtD
Ivermectin—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00479	CcSEcCtD
Ivermectin—NR1H4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00173	0.0128	CbGpPWpGaD
Ivermectin—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00171	0.00471	CcSEcCtD
Ivermectin—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0017	0.0126	CbGpPWpGaD
Ivermectin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00169	0.00466	CcSEcCtD
Ivermectin—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00462	CcSEcCtD
Ivermectin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00166	0.0123	CbGpPWpGaD
Ivermectin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00165	0.00454	CcSEcCtD
Ivermectin—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.00453	CcSEcCtD
Ivermectin—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00162	0.00448	CcSEcCtD
Ivermectin—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00161	0.00445	CcSEcCtD
Ivermectin—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00161	0.00445	CcSEcCtD
Ivermectin—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00161	0.00442	CcSEcCtD
Ivermectin—NR1H4—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.00158	0.0118	CbGpPWpGaD
Ivermectin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00157	0.00433	CcSEcCtD
Ivermectin—NR1H4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00155	0.0115	CbGpPWpGaD
Ivermectin—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00154	0.00425	CcSEcCtD
Ivermectin—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00152	0.00418	CcSEcCtD
Ivermectin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00152	0.00418	CcSEcCtD
Ivermectin—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.0015	0.00415	CcSEcCtD
Ivermectin—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.0015	0.00415	CcSEcCtD
Ivermectin—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.0015	0.00415	CcSEcCtD
Ivermectin—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00149	0.00412	CcSEcCtD
Ivermectin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00146	0.00402	CcSEcCtD
Ivermectin—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00146	0.00402	CcSEcCtD
Ivermectin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00145	0.00399	CcSEcCtD
Ivermectin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00144	0.00398	CcSEcCtD
Ivermectin—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00144	0.00398	CcSEcCtD
Ivermectin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00144	0.00396	CcSEcCtD
Ivermectin—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00143	0.00394	CcSEcCtD
Ivermectin—NR1H4—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.00142	0.0106	CbGpPWpGaD
Ivermectin—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00141	0.00388	CcSEcCtD
Ivermectin—NR1H4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.0014	0.0104	CbGpPWpGaD
Ivermectin—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.00139	0.0103	CbGpPWpGaD
Ivermectin—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.00383	CcSEcCtD
Ivermectin—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.0038	CcSEcCtD
Ivermectin—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00138	0.0038	CcSEcCtD
Ivermectin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00136	0.00376	CcSEcCtD
Ivermectin—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00368	CcSEcCtD
Ivermectin—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00368	CcSEcCtD
Ivermectin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00133	0.00367	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00362	CcSEcCtD
Ivermectin—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00361	CcSEcCtD
Ivermectin—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00359	CcSEcCtD
Ivermectin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.0013	0.00968	CbGpPWpGaD
Ivermectin—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.0013	0.00964	CbGpPWpGaD
Ivermectin—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00348	CcSEcCtD
Ivermectin—NR1H4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00125	0.00931	CbGpPWpGaD
Ivermectin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00125	0.00345	CcSEcCtD
Ivermectin—NR1H4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00125	0.00929	CbGpPWpGaD
Ivermectin—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00343	CcSEcCtD
Ivermectin—Cough—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00343	CcSEcCtD
Ivermectin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.0034	CcSEcCtD
Ivermectin—Cough—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00336	CcSEcCtD
Ivermectin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.00335	CcSEcCtD
Ivermectin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00335	CcSEcCtD
Ivermectin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00335	CcSEcCtD
Ivermectin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00335	CcSEcCtD
Ivermectin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00335	CcSEcCtD
Ivermectin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00335	CcSEcCtD
Ivermectin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00335	CcSEcCtD
Ivermectin—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.00121	0.009	CbGpPWpGaD
Ivermectin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00334	CcSEcCtD
Ivermectin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00334	CcSEcCtD
Ivermectin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00333	CcSEcCtD
Ivermectin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00333	CcSEcCtD
Ivermectin—ABCC1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0012	0.00893	CbGpPWpGaD
Ivermectin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00331	CcSEcCtD
Ivermectin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00331	CcSEcCtD
Ivermectin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00328	CcSEcCtD
Ivermectin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00328	CcSEcCtD
Ivermectin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00325	CcSEcCtD
Ivermectin—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00324	CcSEcCtD
Ivermectin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00324	CcSEcCtD
Ivermectin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00321	CcSEcCtD
Ivermectin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00321	CcSEcCtD
Ivermectin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00316	CcSEcCtD
Ivermectin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00316	CcSEcCtD
Ivermectin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00316	CcSEcCtD
Ivermectin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00316	CcSEcCtD
Ivermectin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00314	CcSEcCtD
Ivermectin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00314	CcSEcCtD
Ivermectin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00313	CcSEcCtD
Ivermectin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00313	CcSEcCtD
Ivermectin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00312	CcSEcCtD
Ivermectin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00311	CcSEcCtD
Ivermectin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00308	CcSEcCtD
Ivermectin—NR1H4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.0011	0.00819	CbGpPWpGaD
Ivermectin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00303	CcSEcCtD
Ivermectin—NR1H4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00109	0.0081	CbGpPWpGaD
Ivermectin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00109	0.003	CcSEcCtD
Ivermectin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.003	CcSEcCtD
Ivermectin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00298	CcSEcCtD
Ivermectin—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.00298	CcSEcCtD
Ivermectin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00296	CcSEcCtD
Ivermectin—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00106	0.00791	CbGpPWpGaD
Ivermectin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.00293	CcSEcCtD
Ivermectin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00293	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00292	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00292	CcSEcCtD
Ivermectin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00289	CcSEcCtD
Ivermectin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00289	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00286	CcSEcCtD
Ivermectin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00286	CcSEcCtD
Ivermectin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00286	CcSEcCtD
Ivermectin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00285	CcSEcCtD
Ivermectin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00285	CcSEcCtD
Ivermectin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00283	CcSEcCtD
Ivermectin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.00281	CcSEcCtD
Ivermectin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00279	CcSEcCtD
Ivermectin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00279	CcSEcCtD
Ivermectin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00101	0.0075	CbGpPWpGaD
Ivermectin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.001	0.00277	CcSEcCtD
Ivermectin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00277	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00276	CcSEcCtD
Ivermectin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000996	0.00274	CcSEcCtD
Ivermectin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000996	0.00274	CcSEcCtD
Ivermectin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000996	0.00274	CcSEcCtD
Ivermectin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000996	0.00274	CcSEcCtD
Ivermectin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000983	0.00271	CcSEcCtD
Ivermectin—ABCG2—Iron uptake and transport—HMOX1—chronic obstructive pulmonary disease	0.000982	0.0073	CbGpPWpGaD
Ivermectin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00098	0.0027	CcSEcCtD
Ivermectin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000977	0.00269	CcSEcCtD
Ivermectin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000975	0.00269	CcSEcCtD
Ivermectin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000973	0.00268	CcSEcCtD
Ivermectin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000965	0.00266	CcSEcCtD
Ivermectin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000964	0.00266	CcSEcCtD
Ivermectin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000961	0.00265	CcSEcCtD
Ivermectin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000959	0.00264	CcSEcCtD
Ivermectin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000959	0.00264	CcSEcCtD
Ivermectin—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000959	0.00713	CbGpPWpGaD
Ivermectin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000958	0.00264	CcSEcCtD
Ivermectin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000956	0.00263	CcSEcCtD
Ivermectin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000954	0.00263	CcSEcCtD
Ivermectin—NR1H4—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.000952	0.00707	CbGpPWpGaD
Ivermectin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000952	0.00262	CcSEcCtD
Ivermectin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000952	0.00262	CcSEcCtD
Ivermectin—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000951	0.00262	CcSEcCtD
Ivermectin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000948	0.00261	CcSEcCtD
Ivermectin—ABCC2—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000942	0.007	CbGpPWpGaD
Ivermectin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00094	0.00259	CcSEcCtD
Ivermectin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00094	0.00259	CcSEcCtD
Ivermectin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000932	0.00257	CcSEcCtD
Ivermectin—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000932	0.00692	CbGpPWpGaD
Ivermectin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000925	0.00255	CcSEcCtD
Ivermectin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000925	0.00255	CcSEcCtD
Ivermectin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00092	0.00254	CcSEcCtD
Ivermectin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00092	0.00254	CcSEcCtD
Ivermectin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00092	0.00254	CcSEcCtD
Ivermectin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00092	0.00254	CcSEcCtD
Ivermectin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000917	0.00253	CcSEcCtD
Ivermectin—NR1H4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000916	0.00681	CbGpPWpGaD
Ivermectin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00091	0.00251	CcSEcCtD
Ivermectin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000909	0.00251	CcSEcCtD
Ivermectin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000909	0.0025	CcSEcCtD
Ivermectin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000906	0.0025	CcSEcCtD
Ivermectin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000906	0.0025	CcSEcCtD
Ivermectin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000904	0.00249	CcSEcCtD
Ivermectin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000901	0.00249	CcSEcCtD
Ivermectin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000901	0.00249	CcSEcCtD
Ivermectin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.0009	0.00248	CcSEcCtD
Ivermectin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000899	0.00248	CcSEcCtD
Ivermectin—ABCC1—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000888	0.00659	CbGpPWpGaD
Ivermectin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000877	0.00652	CbGpPWpGaD
Ivermectin—ABCC1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000874	0.00649	CbGpPWpGaD
Ivermectin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000873	0.00241	CcSEcCtD
Ivermectin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000869	0.0024	CcSEcCtD
Ivermectin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000869	0.0024	CcSEcCtD
Ivermectin—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000868	0.00645	CbGpPWpGaD
Ivermectin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000858	0.00236	CcSEcCtD
Ivermectin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000858	0.00236	CcSEcCtD
Ivermectin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000857	0.00236	CcSEcCtD
Ivermectin—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000854	0.00236	CcSEcCtD
Ivermectin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00084	0.00232	CcSEcCtD
Ivermectin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000835	0.0023	CcSEcCtD
Ivermectin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000835	0.0023	CcSEcCtD
Ivermectin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000824	0.00227	CcSEcCtD
Ivermectin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000824	0.00227	CcSEcCtD
Ivermectin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000818	0.00226	CcSEcCtD
Ivermectin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000811	0.00224	CcSEcCtD
Ivermectin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00081	0.00223	CcSEcCtD
Ivermectin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000807	0.00222	CcSEcCtD
Ivermectin—GABRB3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.0008	0.00594	CbGpPWpGaD
Ivermectin—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000798	0.00593	CbGpPWpGaD
Ivermectin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000797	0.0022	CcSEcCtD
Ivermectin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000797	0.0022	CcSEcCtD
Ivermectin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000789	0.00217	CcSEcCtD
Ivermectin—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000785	0.00216	CcSEcCtD
Ivermectin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00078	0.00215	CcSEcCtD
Ivermectin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000779	0.00579	CbGpPWpGaD
Ivermectin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000778	0.00214	CcSEcCtD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000775	0.00576	CbGpPWpGaD
Ivermectin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00077	0.00212	CcSEcCtD
Ivermectin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00077	0.00212	CcSEcCtD
Ivermectin—NR1H4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000764	0.00568	CbGpPWpGaD
Ivermectin—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000764	0.00568	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000757	0.00563	CbGpPWpGaD
Ivermectin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000754	0.00208	CcSEcCtD
Ivermectin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000752	0.00207	CcSEcCtD
Ivermectin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00074	0.00204	CcSEcCtD
Ivermectin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00074	0.00204	CcSEcCtD
Ivermectin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000734	0.00202	CcSEcCtD
Ivermectin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000734	0.00202	CcSEcCtD
Ivermectin—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000734	0.00545	CbGpPWpGaD
Ivermectin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000733	0.00202	CcSEcCtD
Ivermectin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000733	0.00202	CcSEcCtD
Ivermectin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000729	0.00201	CcSEcCtD
Ivermectin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000729	0.00201	CcSEcCtD
Ivermectin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000727	0.002	CcSEcCtD
Ivermectin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000725	0.002	CcSEcCtD
Ivermectin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000719	0.00198	CcSEcCtD
Ivermectin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000718	0.00198	CcSEcCtD
Ivermectin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000714	0.00197	CcSEcCtD
Ivermectin—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000713	0.0053	CbGpPWpGaD
Ivermectin—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000706	0.00524	CbGpPWpGaD
Ivermectin—NR1H4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000702	0.00522	CbGpPWpGaD
Ivermectin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000699	0.00193	CcSEcCtD
Ivermectin—GLRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000697	0.00518	CbGpPWpGaD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000697	0.00518	CbGpPWpGaD
Ivermectin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000694	0.00191	CcSEcCtD
Ivermectin—ABCC2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000693	0.00515	CbGpPWpGaD
Ivermectin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000693	0.00191	CcSEcCtD
Ivermectin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000692	0.00191	CcSEcCtD
Ivermectin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000692	0.00191	CcSEcCtD
Ivermectin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000692	0.00191	CcSEcCtD
Ivermectin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000689	0.0019	CcSEcCtD
Ivermectin—ABCC1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000685	0.00509	CbGpPWpGaD
Ivermectin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000677	0.00187	CcSEcCtD
Ivermectin—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000675	0.00501	CbGpPWpGaD
Ivermectin—ABCC2—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000671	0.00499	CbGpPWpGaD
Ivermectin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000669	0.00185	CcSEcCtD
Ivermectin—NR1H4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000666	0.00495	CbGpPWpGaD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000657	0.00488	CbGpPWpGaD
Ivermectin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000653	0.0018	CcSEcCtD
Ivermectin—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000652	0.00485	CbGpPWpGaD
Ivermectin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00065	0.00179	CcSEcCtD
Ivermectin—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000642	0.00477	CbGpPWpGaD
Ivermectin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000637	0.00473	CbGpPWpGaD
Ivermectin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000631	0.00174	CcSEcCtD
Ivermectin—ABCC2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000618	0.00459	CbGpPWpGaD
Ivermectin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000615	0.0017	CcSEcCtD
Ivermectin—ABCC2—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000614	0.00456	CbGpPWpGaD
Ivermectin—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000613	0.00455	CbGpPWpGaD
Ivermectin—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000612	0.00454	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000611	0.00454	CbGpPWpGaD
Ivermectin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00061	0.00168	CcSEcCtD
Ivermectin—ABCG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000603	0.00448	CbGpPWpGaD
Ivermectin—ABCC2—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000582	0.00433	CbGpPWpGaD
Ivermectin—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00058	0.00431	CbGpPWpGaD
Ivermectin—ABCC2—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000571	0.00424	CbGpPWpGaD
Ivermectin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000539	0.00149	CcSEcCtD
Ivermectin—ABCG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000537	0.00399	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—APIP—chronic obstructive pulmonary disease	0.000536	0.00398	CbGpPWpGaD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000534	0.00397	CbGpPWpGaD
Ivermectin—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000533	0.00396	CbGpPWpGaD
Ivermectin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00052	0.00143	CcSEcCtD
Ivermectin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000519	0.00143	CcSEcCtD
Ivermectin—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000513	0.00381	CbGpPWpGaD
Ivermectin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000504	0.00139	CcSEcCtD
Ivermectin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000501	0.00138	CcSEcCtD
Ivermectin—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.0005	0.00371	CbGpPWpGaD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000498	0.0037	CbGpPWpGaD
Ivermectin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.00049	0.00364	CbGpPWpGaD
Ivermectin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000486	0.00134	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000486	0.00361	CbGpPWpGaD
Ivermectin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00048	0.00357	CbGpPWpGaD
Ivermectin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000478	0.00132	CcSEcCtD
Ivermectin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000478	0.00132	CcSEcCtD
Ivermectin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000472	0.0013	CcSEcCtD
Ivermectin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000465	0.00128	CcSEcCtD
Ivermectin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000458	0.00126	CcSEcCtD
Ivermectin—NR1H4—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000454	0.00338	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000447	0.00332	CbGpPWpGaD
Ivermectin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000447	0.00123	CcSEcCtD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000443	0.00329	CbGpPWpGaD
Ivermectin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000443	0.00122	CcSEcCtD
Ivermectin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000437	0.0012	CcSEcCtD
Ivermectin—ABCC2—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000431	0.0032	CbGpPWpGaD
Ivermectin—ABCC2—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000425	0.00316	CbGpPWpGaD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000419	0.00312	CbGpPWpGaD
Ivermectin—GLRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000419	0.00311	CbGpPWpGaD
Ivermectin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000417	0.00115	CcSEcCtD
Ivermectin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000417	0.00115	CcSEcCtD
Ivermectin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000398	0.0011	CcSEcCtD
Ivermectin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000398	0.0011	CcSEcCtD
Ivermectin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000397	0.00109	CcSEcCtD
Ivermectin—ABCC2—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000396	0.00294	CbGpPWpGaD
Ivermectin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000395	0.00109	CcSEcCtD
Ivermectin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000395	0.00109	CcSEcCtD
Ivermectin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000392	0.00108	CcSEcCtD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000382	0.00284	CbGpPWpGaD
Ivermectin—ABCG2—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000379	0.00282	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000379	0.00281	CbGpPWpGaD
Ivermectin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000378	0.00104	CcSEcCtD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000377	0.0028	CbGpPWpGaD
Ivermectin—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000377	0.0028	CbGpPWpGaD
Ivermectin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000375	0.00103	CcSEcCtD
Ivermectin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000375	0.00103	CcSEcCtD
Ivermectin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000364	0.001	CcSEcCtD
Ivermectin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000362	0.000998	CcSEcCtD
Ivermectin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000362	0.000998	CcSEcCtD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000355	0.00264	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000355	0.00264	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000352	0.00261	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—GC—chronic obstructive pulmonary disease	0.000345	0.00256	CbGpPWpGaD
Ivermectin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000338	0.000931	CcSEcCtD
Ivermectin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000329	0.000906	CcSEcCtD
Ivermectin—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000326	0.00242	CbGpPWpGaD
Ivermectin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000324	0.000894	CcSEcCtD
Ivermectin—NR1H4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000321	0.00238	CbGpPWpGaD
Ivermectin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000313	0.000864	CcSEcCtD
Ivermectin—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000312	0.00231	CbGpPWpGaD
Ivermectin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000305	0.00226	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000304	0.00226	CbGpPWpGaD
Ivermectin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000303	0.000835	CcSEcCtD
Ivermectin—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000301	0.00223	CbGpPWpGaD
Ivermectin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000291	0.000803	CcSEcCtD
Ivermectin—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000291	0.00216	CbGpPWpGaD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000289	0.00215	CbGpPWpGaD
Ivermectin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000289	0.000796	CcSEcCtD
Ivermectin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000289	0.000796	CcSEcCtD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000288	0.00214	CbGpPWpGaD
Ivermectin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000287	0.000791	CcSEcCtD
Ivermectin—NR1H4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000275	0.00204	CbGpPWpGaD
Ivermectin—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000274	0.00203	CbGpPWpGaD
Ivermectin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000272	0.00075	CcSEcCtD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000269	0.002	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000262	0.00194	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000256	0.0019	CbGpPWpGaD
Ivermectin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000247	0.00183	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	0.00023	0.00171	CbGpPWpGaD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000227	0.00168	CbGpPWpGaD
Ivermectin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000221	0.00164	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000219	0.00163	CbGpPWpGaD
Ivermectin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000218	0.00162	CbGpPWpGaD
Ivermectin—NR1H4—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000207	0.00154	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000204	0.00151	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000189	0.0014	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000187	0.00139	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000186	0.00138	CbGpPWpGaD
Ivermectin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000179	0.00133	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000174	0.00129	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000173	0.00129	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000172	0.00128	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00017	0.00126	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—GC—chronic obstructive pulmonary disease	0.000169	0.00125	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000166	0.00124	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000165	0.00123	CbGpPWpGaD
Ivermectin—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000161	0.0012	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.00016	0.00119	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000158	0.00117	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000157	0.00116	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000157	0.00116	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000156	0.00116	CbGpPWpGaD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000156	0.00116	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000152	0.00113	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000149	0.0011	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	0.000148	0.0011	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000138	0.00102	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000136	0.00101	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	0.000135	0.001	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000134	0.000999	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000131	0.000975	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000131	0.000971	CbGpPWpGaD
Ivermectin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000129	0.000961	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000129	0.000958	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000125	0.000928	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000124	0.000925	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	0.000124	0.000921	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.00012	0.000892	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000118	0.000879	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	0.000116	0.00086	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.000846	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000109	0.000813	CbGpPWpGaD
Ivermectin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000108	0.000802	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000101	0.000747	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	9.97e-05	0.000741	CbGpPWpGaD
Ivermectin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.92e-05	0.000737	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.53e-05	0.000708	CbGpPWpGaD
Ivermectin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.4e-05	0.000698	CbGpPWpGaD
Ivermectin—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	9.24e-05	0.000687	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.21e-05	0.000684	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.1e-05	0.000676	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.92e-05	0.000663	CbGpPWpGaD
Ivermectin—ABCC1—Disease—KL—chronic obstructive pulmonary disease	8.59e-05	0.000638	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.49e-05	0.000631	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.31e-05	0.000617	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.24e-05	0.000613	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.17e-05	0.000607	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.1e-05	0.000602	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.07e-05	0.0006	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	8.02e-05	0.000596	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.01e-05	0.000595	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—ALB—chronic obstructive pulmonary disease	7.74e-05	0.000575	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	7.67e-05	0.00057	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.65e-05	0.000569	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.46e-05	0.000554	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.4e-05	0.00055	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.31e-05	0.000543	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.1e-05	0.000528	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.73e-05	0.0005	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	6.66e-05	0.000495	CbGpPWpGaD
Ivermectin—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	6.44e-05	0.000479	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.39e-05	0.000475	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.38e-05	0.000474	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.3e-05	0.000468	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	6.12e-05	0.000454	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	6e-05	0.000446	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.87e-05	0.000436	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	5.71e-05	0.000424	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.62e-05	0.000417	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.56e-05	0.000413	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.54e-05	0.000412	CbGpPWpGaD
Ivermectin—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	5.37e-05	0.000399	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.16e-05	0.000384	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.08e-05	0.000377	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.04e-05	0.000374	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.94e-05	0.000367	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.89e-05	0.000364	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.59e-05	0.000341	CbGpPWpGaD
Ivermectin—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	4.52e-05	0.000336	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.38e-05	0.000326	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.33e-05	0.000322	CbGpPWpGaD
Ivermectin—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	4.32e-05	0.000321	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.95e-05	0.000294	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.84e-05	0.000285	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	3.78e-05	0.000281	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.64e-05	0.000271	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.62e-05	0.000269	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	3.33e-05	0.000247	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.18e-05	0.000236	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.04e-05	0.000226	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3e-05	0.000223	CbGpPWpGaD
Ivermectin—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	2.86e-05	0.000212	CbGpPWpGaD
Ivermectin—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	2.8e-05	0.000208	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.79e-05	0.000207	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.7e-05	0.000201	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.67e-05	0.000198	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.65e-05	0.000197	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.43e-05	0.000181	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.24e-05	0.000167	CbGpPWpGaD
Ivermectin—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	2.15e-05	0.00016	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.87e-05	0.000139	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.85e-05	0.000137	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.8e-05	0.000134	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.72e-05	0.000128	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.72e-05	0.000128	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.63e-05	0.000121	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.11e-05	8.23e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.06e-05	7.87e-05	CbGpPWpGaD
